Human PAI-1 (stable vitronectin reduced binding mutant)

Human PAI-1 (stable vitronectin binding negative mutant)

$695$1,140

Clear
Cat #: CPAI-QR. Categories: , .

Product Description

Human PAI-1 (stable vitronectin binding negative mutant)

A double mutation (Q123K and R101A) on the human PAI-1 stable mutant background (K154T, Q319L, M354I and N150H) results in PAI-1 with a greatly extended half life and greatly reduced binding to the important ligand vitronectin.
References
Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal. Jensen JK, Durand MK, Skeldal S, Dupont DM, Bødker JS, Wind T, Andreasen PA. FEBS Lett. 2004 Jan 2;556(1-3):175-9.
Conservation of Critical Functional Domains in Murine Plasminogen Activator Inhibitor-1. Zhi Xu, Rashna D. Balsara, Natalia V. Gorlatova, Daniel A. Lawrence, Francis J. Castellino, and Victoria A. Ploplis. J. Biol. Chem., Apr 2004; 279:17914-20.

Gene ID: 5054
Swiss-Prot/UniProt ID: P05121

View sample datasheet
View sample certificate of analysis
View material safety data sheet
Ask a question about this product

Additional Information

purity

>95% by SDS-PAGE analysis

source

E. coli

Molecular Weight

43,000

Extinction Coefficient

1

species

Human

storage

-70 C

Shipping Conditions

Dry ice

expiration

3 years from delivery

form

Frozen liquid

buffer

0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6

Sample Size

0.5 mg

Sample Concentration

2.5 mg/ml

Sample Volume

0.2 ml

Gene Name

SERPINE1

Gene ID

5054

UniProt ID

P05121

1. Wan YZ, Gao P, Zhou S, et al. SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence. Aging Cell. 2014;13(5):890-9. link to article